IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager

IRLAB Therapeutics AB

STO:IRLAB A

Watchlist

Dividends

Price: 13.1 SEK 8.26% Market Closed

Market Cap: 678.4m SEK

Have any thoughts about
IRLAB Therapeutics AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Matson Inc NYSE:MATX	Marine
US	Uber Technologies Inc NYSE:UBER	Road & Rail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	United Airlines Holdings Inc NASDAQ:UAL	Airlines
US	Apple Inc NASDAQ:AAPL	Technology
US	Alphabet Inc NASDAQ:GOOGL	Media

Add Price Alert

Price Target:

Last Price: 13.1 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IRLAB A Alert

IRLAB Therapeutics AB

13.1

+1.0 (+8.26%)

52 Week Range	5.9 19.6
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Matson Inc NYSE:MATX	US
	Uber Technologies Inc NYSE:UBER	US
	JPMorgan Chase & Co NYSE:JPM	US
	United Airlines Holdings Inc NASDAQ:UAL	US
	Apple Inc NASDAQ:AAPL	US
	Alphabet Inc NASDAQ:GOOGL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

IRLAB Therapeutics AB

What unique competitive advantages
does IRLAB Therapeutics AB hold over its rivals?

What risks and challenges
does IRLAB Therapeutics AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of IRLAB Therapeutics AB.

What unique competitive advantages
does IRLAB Therapeutics AB hold over its rivals?

What risks and challenges
does IRLAB Therapeutics AB face in the near future?

Has there been any significant insider trading activity
in IRLAB Therapeutics AB recently?

Summarize the latest earnings call
of IRLAB Therapeutics AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IRLAB Therapeutics AB.

Provide P/S
for IRLAB Therapeutics AB.

Provide P/E
for IRLAB Therapeutics AB.

Provide P/OCF
for IRLAB Therapeutics AB.

Provide P/FCFE
for IRLAB Therapeutics AB.

Provide P/B
for IRLAB Therapeutics AB.

Provide EV/S
for IRLAB Therapeutics AB.

Provide EV/GP
for IRLAB Therapeutics AB.

Provide EV/EBITDA
for IRLAB Therapeutics AB.

Provide EV/EBIT
for IRLAB Therapeutics AB.

Provide EV/OCF
for IRLAB Therapeutics AB.

Provide EV/FCFF
for IRLAB Therapeutics AB.

Provide EV/IC
for IRLAB Therapeutics AB.

Show me price targets
for IRLAB Therapeutics AB made by professional analysts.

What are the Revenue projections
for IRLAB Therapeutics AB?

How accurate were the past Revenue estimates
for IRLAB Therapeutics AB?

What are the Net Income projections
for IRLAB Therapeutics AB?

How accurate were the past Net Income estimates
for IRLAB Therapeutics AB?

What are the EPS projections
for IRLAB Therapeutics AB?

How accurate were the past EPS estimates
for IRLAB Therapeutics AB?

What are the EBIT projections
for IRLAB Therapeutics AB?

How accurate were the past EBIT estimates
for IRLAB Therapeutics AB?

Compare the revenue forecasts
for IRLAB Therapeutics AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IRLAB Therapeutics AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IRLAB Therapeutics AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of IRLAB Therapeutics AB compared to its peers.

Compare the P/E ratios
of IRLAB Therapeutics AB against its peers.

Discuss the investment returns and shareholder value creation
comparing IRLAB Therapeutics AB with its peers.

Analyze the financial leverage
of IRLAB Therapeutics AB compared to its main competitors.

Show all profitability ratios
for IRLAB Therapeutics AB.

Provide ROE
for IRLAB Therapeutics AB.

Provide ROA
for IRLAB Therapeutics AB.

Provide ROIC
for IRLAB Therapeutics AB.

Provide ROCE
for IRLAB Therapeutics AB.

Provide Gross Margin
for IRLAB Therapeutics AB.

Provide Operating Margin
for IRLAB Therapeutics AB.

Provide Net Margin
for IRLAB Therapeutics AB.

Provide FCF Margin
for IRLAB Therapeutics AB.

Show all solvency ratios
for IRLAB Therapeutics AB.

Provide D/E Ratio
for IRLAB Therapeutics AB.

Provide D/A Ratio
for IRLAB Therapeutics AB.

Provide Interest Coverage Ratio
for IRLAB Therapeutics AB.

Provide Altman Z-Score Ratio
for IRLAB Therapeutics AB.

Provide Quick Ratio
for IRLAB Therapeutics AB.

Provide Current Ratio
for IRLAB Therapeutics AB.

Provide Cash Ratio
for IRLAB Therapeutics AB.

What is the historical Revenue growth
over the last 5 years for IRLAB Therapeutics AB?

What is the historical Net Income growth
over the last 5 years for IRLAB Therapeutics AB?

What is the current Free Cash Flow
of IRLAB Therapeutics AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for IRLAB Therapeutics AB.

P/B
Price to Book Value

17.9

Current

5.3

Median

2.1

Industry

Higher than median

Higher than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

17.9

Market Cap

679.5m SEK

Book Value of Equity

38m SEK

All Countries

Forward Multiples

			Market Cap	P/B
SE		IRLAB Therapeutics AB STO:IRLAB A	679.5m SEK	17.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-21 763 099
US		Eli Lilly and Co NYSE:LLY	710.5B USD	49.9
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	583.1
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	27.5
US		Johnson & Johnson NYSE:JNJ	373.5B USD	5.3
US		Merck & Co Inc NYSE:MRK	251.1B USD	5.6
CH		Roche Holding AG SIX:ROG	202.7B CHF	6.9
CH		Novartis AG SIX:NOVN	183.3B CHF	5.2
UK		AstraZeneca PLC LSE:AZN	162.4B GBP	5.2
IE	E	Endo International PLC LSE:0Y5F	146B USD	-35.4


SE		IRLAB Therapeutics AB STO:IRLAB A	Average P/B: 78.5 17.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -21 763 099
US		Eli Lilly and Co NYSE:LLY	49.9
UK		Dechra Pharmaceuticals PLC LSE:DPH	583.1
DK		Novo Nordisk A/S CSE:NOVO B	27.5
US		Johnson & Johnson NYSE:JNJ	5.3
US		Merck & Co Inc NYSE:MRK	5.6
CH		Roche Holding AG SIX:ROG	6.9
CH		Novartis AG SIX:NOVN	5.2
UK		AstraZeneca PLC LSE:AZN	5.2
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -35.4

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

IRLAB Therapeutics AB
STO:IRLAB A

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

IRLAB Therapeutics AB STO:IRLAB A

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

IRLAB Therapeutics AB
STO:IRLAB A

P/B
Price to Book Value